Q3 2025 Earnings Call Transcript November 13, 2025 Operator: Thank you for standing by. My name is Tina, and I will be your ...
Generated $131 million from the successful business combination with GSR III Acquisition Corp. and related equity financing on October 9, ...
BioLife Solutions ( ($BLFS) ) has issued an update. On November 17, 2025, BioLife Solutions released an investor presentation highlighting its ...
Predictive Oncology (Nasdaq: POAI) , an AI-driven drug discovery company that has expanded its business to include a digital asset strategy focused on ATH, the native utility token of the Aethir ...
Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsBob BurrowsJoshua Resnik - President, CEO ...
Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE, Pa., Nov. 03, 2025 (GLOBE NEWSWIRE) -- -- NEXGEL, Inc. ("NEXGEL” or the "Company”) (NASDAQ: "NXGL”), a leading ...
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of ...
DUBLIN, Oct. 22, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 third quarter financial results on Wednesday, November 5, 2025, after the ...
Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that 12 abstracts have been accepted for presentation at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback